Walnut Creek, CALIFORNIA3 Active Studies

Spinal Muscular Atrophy Clinical Trials in Walnut Creek, CALIFORNIA

Find 3 actively recruiting spinal muscular atrophy clinical trials in Walnut Creek, CALIFORNIA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
2,000
Enrolling

Recruiting Spinal Muscular Atrophy Studies in Walnut Creek

About Spinal Muscular Atrophy Clinical Trials in Walnut Creek

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.

There are currently 3 spinal muscular atrophy clinical trials recruiting participants in Walnut Creek, CALIFORNIA. These studies are seeking a combined 2,000 participants. Research is being sponsored by AstraZeneca, OncoC4, Inc., Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Spinal Muscular Atrophy Clinical Trials in Walnut Creek — FAQ

Are there spinal muscular atrophy clinical trials in Walnut Creek?

Yes, there are 3 spinal muscular atrophy clinical trials currently recruiting in Walnut Creek, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Walnut Creek?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Walnut Creek research site will contact you about next steps.

Are clinical trials in Walnut Creek free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Walnut Creek studies also compensate for your time and travel.

What spinal muscular atrophy treatments are being tested?

The 3 active trials in Walnut Creek are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.

Data updated March 2, 2026 from ClinicalTrials.gov